OverviewSuggest Edit

Quest Diagnostics is a company providing diagnostic testing, information, and services. It offers diagnostic testing services through its network of laboratories and patient service centers, interpretive consultation through its medical and scientific staff, cancer diagnostics, and anatomic pathology services. The company serves patients, healthcare providers, pharmaceutical medical device companies, life insurance companies, and employers.

TypePublic
Founded1967
HQSecaucus, NJ, US
Websitequestdiagnostics.com
Employee Ratings3.5
Overall CultureC+

Latest Updates

Employees (est.) (Dec 2020)40,000
Job Openings2,577
Revenue (FY, 2020)$9.4 B(+23%)
Share Price (Sept 2021)$154.8
Cybersecurity ratingBMore

Key People/Management at Quest Diagnostics

Stephen H. Rusckowski

Stephen H. Rusckowski

Chairman of the Board, Chief Executive Officer and President
Mark J. Guinan

Mark J. Guinan

Executive Vice President and Chief Financial Officer
Cecilia McKenney

Cecilia McKenney

Senior Vice President, Chief Human Resources Officer
Tim Sharpe

Tim Sharpe

Vice President, Compliance
Shawn Bevec

Shawn Bevec

Vice President, Investor Relations
Gabrielle Wolfson

Gabrielle Wolfson

Senior Vice President, Chief Information & Digital Officer
Show more

Quest Diagnostics Office Locations

Quest Diagnostics has offices in Secaucus, Santana De Parnaiba, Dublin and Ciudad de México
Secaucus, NJ, US (HQ)
500 Plaza Dr
Santana De Parnaiba, BR
1818 Estrada Tenente Marques, A06 & A07
Dublin, IE
Block 1, Unit 10, 9 Northwood Ave, Northside
Ciudad de México, MX
Frontera 4, Roma Nte., Cuauhtémoc
Ciudad de México, MX
World Trade Center 9th Floor, Office 19 Col. Napoles, Deleg. Benito Juarez
Show all (5)

Quest Diagnostics Financials and Metrics

Quest Diagnostics Revenue

Embed Graph
View revenue for all periods
Quest Diagnostics's revenue was reported to be $9.44 b in FY, 2020 which is a 22.1% increase from the previous period.
USD

Revenue (Q1, 2021)

2.7b

Gross profit (Q1, 2021)

1.1b

Gross profit margin (Q1, 2021), %

40.2%

Net income (Q1, 2021)

490.0m

EBIT (Q1, 2021)

660.0m

Market capitalization (14-Sept-2021)

18.8b

Closing stock price (14-Sept-2021)

154.8

Cash (31-Mar-2021)

1.2b

EV

22.3b
Quest Diagnostics's current market capitalization is $18.8 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

7.5b7.7b9.4b

Revenue growth, %

3%22%

Cost of goods sold

4.9b5.0b5.8b

Gross profit

2.6b2.7b3.6b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

1.9b2.0b2.0b1.8b1.8b2.8b2.7b

Cost of goods sold

1.2b1.3b1.3b1.3b1.2b1.6b1.6b

Gross profit

647.0m688.0m692.0m552.0m606.0m1.2b1.1b

Gross profit Margin, %

34%35%35%30%33%43%40%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

135.0m1.2b1.2b

Accounts Receivable

1.0b1.1b1.5b

Prepaid Expenses

144.0m112.0m157.0m

Inventories

99.0m123.0m223.0m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

464.0m273.0m434.0m342.0m988.0m1.6b1.2b

Accounts Receivable

1.1b1.1b1.1b972.0m1.1b1.4b1.4b

Prepaid Expenses

137.0m100.0m116.0m120.0m112.0m117.0m164.0m

Inventories

98.0m105.0m112.0m126.0m154.0m205.0m223.0m
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

788.0m906.0m1.5b

Depreciation and Amortization

309.0m329.0m361.0m

Accounts Payable

(19.0m)73.0m452.0m

Cash From Operating Activities

1.2b1.2b2.0b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

164.0m415.0m641.0m106.0m299.0m890.0m490.0m

Depreciation and Amortization

108.0m165.0m247.0m85.0m174.0m263.0m101.0m

Accounts Payable

32.0m27.0m80.0m(47.0m)42.0m514.0m(164.0m)

Cash From Operating Activities

275.0m596.0m895.0m247.0m602.0m1.5b731.0m
USDFY, 2018

EV/EBIT

13.7 x

EV/CFO

12.6 x

Revenue/Employee

188.3k

Debt/Equity

0.7 x

Debt/Assets

0.4 x

Financial Leverage

2.1 x

P/E Ratio

15.7
Show all financial metrics

Quest Diagnostics Operating Metrics

FY, 2018FY, 2019FY, 2020

Facilities Leased

101111

Facilities Owned

766

Volume (Government Payers), percent

13%12%11%

Volume (Healthcare Insurers), percent

46%46%44%
Show all operating metrics

Quest Diagnostics Acquisitions / Subsidiaries

Company NameDateDeal Size
Mercy - Outreach Laboratory ServicesMarch 08, 2021
MACLJune 24, 2020
Blueprint GeneticsJanuary 22, 2020
PhenoPath LaboratoriesSeptember 27, 2018
ReproSourceSeptember 24, 2018
California Laboratory AssociatesOctober 30, 2017
Cleveland HeartLabOctober 18, 2017
Cape Cod Healthcare - BusinessJune 28, 2017
ClearPoint DiagnosticJune 12, 2017
Med fusionJune 12, 2017
Show more

Quest Diagnostics Revenue Breakdown

Embed Graph

Quest Diagnostics revenue breakdown by business segment: 96.8% from Diagnostic Information Services and 3.2% from Other

Show all human capital metrics

Quest Diagnostics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

81/100

SecurityScorecard logo

Quest Diagnostics Online and Social Media Presence

Embed Graph

Quest Diagnostics Company Culture

  • Overall Culture

    C+

    65/100

  • CEO Rating

    C+

    67/100

  • Compensation

    C+

    64/100

  • Diversity

    B

    71/100

Learn more on Comparably

Quest Diagnostics News and Updates

Quest Diagnostics hikes financial estimates on Delta variant testing boost

Quest Diagnostics Inc. on Thursday raised its 2021 financial outlook on the heels of increased testing activity for Covid-19. Since the company issued its last projections on July 22, it's seen stronger-than-expected molecular testing volumes through the end of August. The surge of the Delta varian…

Quest Diagnostics Updates Outlook For Full Year 2021

SECAUCUS, N.J., Sept. 9, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its financial outlook for full year 2021. Since the company reported its financial performance for the second quarter of...

Quest Diagnostics Elects Tracey C. Doi to Board of Directors

SECAUCUS, N.J., Aug. 17, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Ms. Tracey C. Doi to serve as a director. Including Ms. Doi, the company's Board has 10...

eMed™ and Quest Diagnostics Collaborate to Offer Guided COVID-19 Rapid Antigen Testing to Help Employers Foster Safer Workplaces

Testing can be performed by individuals from the comfort of their home, at their convenience, to encourage compliance and limit exposure in an office setting. New testing option complements Quest's current return-to-work solutions featuring molecular diagnostic and antibody testing. Testing can be p…

Quest Diagnostics adjusted profit more than doubles, beat expectations

Quest Diagnostics Inc. reported Thursday second-quarter adjusted profit that more than doubled to beat expectations, as revenue also topped forecasts, as the recovery in the lab results and diagnostics company cited a faster-than-expected recovery in its base business. Net income rose to $631 milli…

Quest Diagnostics Reports Second Quarter 2021 Financial Results; Establishes Full Year 2021 Outlook

SECAUCUS, N.J., July 22, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2021. "We had another strong quarter, with a faster than...
Show more

Quest Diagnostics Blogs

Cancer Diagnoses Declined Sharply During First Year of COVID-19 Pandemic, Finds Quest Diagnostics Health Trends® Study Published in JAMA Network Open

Nationwide analysis finds declines in the rate of new diagnoses of eight common cancers from March 2020-March 2021 versus prior to the pandemic suggesting a future wave of more advanced disease due to belated diagnoses

Quest Diagnostics Acquires Boca Raton-Based Nationwide Laboratory Services

Physicians and patients to benefit from access to Quest’s industry-leading test menu and network of patient service centers throughout the state

SIM inaugurates the first Post COVID-19 Care Clinic in Puerto Rico

The clinic will offer integrated and multidisciplinary services for the care of patients who have suffered from COVID-19.

TrustAssure™ Announces Travel and Live Event Covid Testing through a Collaboration with Quest Diagnostics

Testing will be available through CLX Health's TrustAssure™ Global Testing Platform for international travelers and live event attendance
Show more

Quest Diagnostics Frequently Asked Questions

  • When was Quest Diagnostics founded?

    Quest Diagnostics was founded in 1967.

  • Who are Quest Diagnostics key executives?

    Quest Diagnostics's key executives are Stephen H. Rusckowski, Mark J. Guinan and Cecilia McKenney.

  • How many employees does Quest Diagnostics have?

    Quest Diagnostics has 40,000 employees.

  • What is Quest Diagnostics revenue?

    Latest Quest Diagnostics annual revenue is $9.4 b.

  • What is Quest Diagnostics revenue per employee?

    Latest Quest Diagnostics revenue per employee is $235.9 k.

  • Who are Quest Diagnostics competitors?

    Competitors of Quest Diagnostics include Invitae, Sonic Healthcare and Abbott.

  • Where is Quest Diagnostics headquarters?

    Quest Diagnostics headquarters is located at 500 Plaza Dr, Secaucus.

  • Where are Quest Diagnostics offices?

    Quest Diagnostics has offices in Secaucus, Santana De Parnaiba, Dublin and Ciudad de México.

  • How many offices does Quest Diagnostics have?

    Quest Diagnostics has 5 offices.